Kyle McClements bought $15k of BMEZ
other at BlackRock Health Sciences Term Trust. 1,000 shares at an average of $14.77, traded Dec 27, 2023, filed Apr 30, 2024.
Score components
- +8RoleOther
- 0Trade size$15k at market
- +6Relative to holdingsHoldings up 44%
- 0Price contextNear the top of the 52-week range
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +5.5%, 3m +12.4%, 6m +14.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-050660, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 27, 2023 | POpen-market purchase Common Stock | +450 | $14.78 | $6,651 | 2,737 | Apr 30, 2024 |
| Dec 27, 2023 | POpen-market purchase Common Stock | +550 | $14.77 | $8,124 | 3,287 | Apr 30, 2024 |
Related signals
Other insiders at BlackRock Health Sciences Term Trust and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 49Moderate | BMEZsell BlackRock Health Sciences Term Trust | Robert W Fairbairn director | $308k 20,589 shares | -200% | |
| 27Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $1.0M 64,716 shares | +0% | |
| 15Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $243k 15,281 shares | +0% | |
| 22Weak | BlackRock Health Sciences Term Trust | Christopher Accettella other | $18k 1,190 shares | +41% | |
| 13Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $150k 9,526 shares | +0% | |
| 13Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $127k 8,012 shares | +0% | |
| 24Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $783k 49,504 shares | +0% | |
| 2Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $4,719 300 shares | +0% | |
| 7Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $32k 2,006 shares | +0% | |
| 15Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $249k 15,455 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.